Malignant blood diseases

Haemolysis in Malignant Blood Diseases.

Blood plasma pseudouridine in patients with malignant proliferative diseases.

The blood plasma concentration of pseudouridine was estimated in 104 healthy adult subjects, and 108 patients suffering from malignant proliferative diseases. The HPLC method for simultaneous determination of pseudouridine and creatinine was applied. The average physiological concentration of pseudouridine in blood plasma was 2.43 +/- 0.97 mumol.l-1 or 29.15 +/- 7.40 mmol.mol-1 creatinine. The ...

Blood groups: In Health and Diseases

ABO blood type antigens are polymorphic, inherited structures presented on the surface of red blood cells. Although ABO blood group antigens is the most important antigens in transfusion medicine, its main role is not clearly clarified. Correlation between ABO blood group and susceptibility to certain infectious and non-infectious diseases is a controversial issue. Since, lack of blood type ant...

Electron Microscopic investigations on sections from lymph nodes and bone marrow in malignant blood diseases.

T HE INTRODUCTION of a miew technic iisto medical science commonly goes through three phases : a period of emithusiasm, a period of rejectiomi ( which sometimes may not be overcome), and a period of reasonable appreciatioms. Electron microscopic cytology has now reached the third state. Enthusiasm has beets justified since resolution power has beets pushed from 3000 A to less thami 30 A ; rejec...

Detection of thyroid peroxidase mRNA in peripheral blood of patients with malignant and benign thyroid diseases.

The aim of this study was to evaluate thyroid peroxidase (TPO) mRNA expression in peripheral blood of patients with benign and malignant thyroid disease. Included were 120 thyroid cancer patients, 85 patients with goitre or Graves' disease (GD) and 54 healthy volunteers. TPO mRNA expression was analysed in peripheral blood by nested RT-PCR. In cancer patients, RT-PCR results were compared with ...